Cancer cells are abnormal cells that can reproduce and regenerate rapidly. They are
characterized by unlimited proliferation, transformation and migration, and can destroy …

While the field of precision oncology is rapidly expanding and more targeted options are
revolutionizing cancer treatment paradigms, therapeutic resistance particularly to …

Pancreatic cancer is currently the most lethal tumor entity and case numbers are rising. It will
soon be the second most frequent cause of cancer-related death in the Western world …

Background Early detection of pancreatic ductal adenocarcinoma (PDAC) may improve the
prognosis of patients. This study was to identify metabolic features of PDAC and to discover …

Simple Summary Pancreatic cancer is a clinically heterogeneous disease, and treatment
leads to different outcomes for people with similar diagnoses. Identifying patients who may …

Simple Summary A highly desirable approach to diagnose a human disease quickly and
easily is to identify a chemical, protein, or antibody in a biofluid like blood or urine that is …

Our study aimed to identify a urinary metabolite panel for the detection/diagnosis of
pancreatic ductal adenocarcinoma (PDAC). PDAC continues to have poor survival …

Pancreatic adenocarcinoma (PAAD) is one of the most common malignant tumors with high
mortality rates and a poor prognosis. There is an urgent need to determine the molecular …

Background & Objectives Pancreatic ductal adenocarcinoma remains an extremely
malignant tumor having a poor prognosis. The 5-year survival rate of PDAC is related to its …

Lithocholic acid (LCA) is a secondary bile acid. LCA enters the circulation after bacterial
synthesis in the gastrointestinal tract, reaches distantly located cancer cells, and influences …